BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 4037991)

  • 21. Plasma cortisol and 11-deoxycortisol activity in depressed patients and normal volunteers.
    Schweitzer I; Tuckwell VM; Maguire KP; Tiller JW; Harrison LC; Davies BM
    Psychoneuroendocrinology; 1991; 16(5):375-82. PubMed ID: 1805291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
    Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple depressive episodes and plasma postdexamethasone cortisol levels.
    Meador-Woodruff JH; Gurguis G; Grunhaus L; Haskett RF; Greden JF
    Biol Psychiatry; 1987 May; 22(5):583-92. PubMed ID: 3580433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortisol escape from suppression by dexamethasone during depression is strongly predicted by basal cortisol hypersecretion and increasing age combined.
    Maes M; Minner B; Suy E; D'Hondt P; Jacobs MP; Raus J
    Psychoneuroendocrinology; 1991; 16(4):295-310. PubMed ID: 1745698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pituitary and adrenocortical responses to the ovine corticotropin releasing hormone in depressed patients and healthy volunteers.
    Amsterdam JD; Maislin G; Winokur A; Kling M; Gold P
    Arch Gen Psychiatry; 1987 Sep; 44(9):775-81. PubMed ID: 2820340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.
    Yehuda R; Southwick SM; Krystal JH; Bremner D; Charney DS; Mason JW
    Am J Psychiatry; 1993 Jan; 150(1):83-6. PubMed ID: 8417586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dexamethasone suppression test in prepubertal depressed children.
    Weller EB; Weller RA; Fristad MA; Preskorn SH; Teare M
    J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
    Thompson LM; Rubin RT; McCracken JT
    Psychoneuroendocrinology; 1992 Oct; 17(5):507-15. PubMed ID: 1484917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circadian analysis of plasma cortisol levels before and after dexamethasone administration in depressed patients.
    Sherman B; Pfohl B; Winokur G
    Arch Gen Psychiatry; 1984 Mar; 41(3):271-5. PubMed ID: 6703845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abnormal pituitary function during melancholia: reduced alpha-melanocyte-stimulating hormone secretion and increased intact ACTH non-suppression.
    Maes M; DeJonckheere C; Vandervorst C; Schotte C; Cosyns P; Raus J; Suy E
    J Affect Disord; 1991 Jul; 22(3):149-57. PubMed ID: 1655852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of sleep deprivation and subsequent recovery sleep on cortisol in unmedicated depressed patients.
    Voderholzer U; Hohagen F; Klein T; Jungnickel J; Kirschbaum C; Berger M; Riemann D
    Am J Psychiatry; 2004 Aug; 161(8):1404-10. PubMed ID: 15285966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salivary cortisol: a practical method for evaluation of adrenal function.
    Kahn JP; Rubinow DR; Davis CL; Kling M; Post RM
    Biol Psychiatry; 1988 Feb; 23(4):335-49. PubMed ID: 3257706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The dexamethasone suppression test in depression. Critical review].
    Bailly D; Goudemand M; Parquet PJ
    Encephale; 1984; 10(4):155-69. PubMed ID: 6389093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cortisol levels in plasma after dexamethasone administration and the nosology of depression.
    Sanchez Blanque A; Fernandez Canti G; Gimenez Morales JC; Juste Rullo G
    Acta Psychiatr Belg; 1985; 85(3):406-15. PubMed ID: 4050499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
    Lemus CZ; Asnis GM; Halbreich U; Harkavy Friedman JM; Van Praag HM; Rubinson E; Eisenberg J
    J Affect Disord; 1987; 12(3):219-21. PubMed ID: 2956306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression.
    Claustrat B; Chazot G; Brun J; Jordan D; Sassolas G
    Biol Psychiatry; 1984 Aug; 19(8):1215-28. PubMed ID: 6498244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns.
    Rubin RT; Poland RE; Lesser IM; Martin DJ; Blodgett AL; Winston RA
    Psychol Med; 1987 Aug; 17(3):609-19. PubMed ID: 3628622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate glucocorticoid feedback of corticotropin secretion in patients with major depression.
    Kellner M; Holsboer F; Heuser I
    Psychiatry Res; 1995 Nov; 59(1-2):157-60. PubMed ID: 8771231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathophysiology of HPA axis abnormalities in patients with major depression: an update.
    Kathol RG; Jaeckle RS; Lopez JF; Meller WH
    Am J Psychiatry; 1989 Mar; 146(3):311-7. PubMed ID: 2645793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma endogenous opioids and dexamethasone suppression test in depression.
    Kärkkäinen J; Laatikainen T; Naukkarinen H; Salminen K; Spoov J; Stenman UH; Rimon R
    Psychiatry Res; 1987 Jun; 21(2):151-9. PubMed ID: 2956623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.